ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly EPS (Basic) of -$1.09 for Q1 2026, up 41.18% year-over-year from -$0.77 in Q1 2025, and up 72.85% quarter-over-quarter from -$4.03 in Q4 2025.
ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported EPS (Basic) for 11 consecutive years, with -$1.09 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 41.18% year-over-year to -$1.09; the TTM figure through Mar 2026 stood at -$6.09 (up 62.06% YoY), while the FY2025 annual figure was -$7.05, up 86.66% from the prior year.
- EPS (Basic) rose to -$1.09 in Q1 2026 per NDRA's latest filing, from -$4.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$1.09 in Q1 2026 and bottomed at -$2323.7 in Q1 2022.
- Historically, EPS (Basic) has averaged -$727.56 across 5 years, with a median of -$401.41 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) slipped 4.89% — and 2025, when it soared 99.59%.
- ENDRA Life Sciences' EPS (Basic) stood at -$1991.3 in 2022, then soared by 79.84% to -$401.41 in 2023, then soared by 95.9% to -$16.46 in 2024, then soared by 75.53% to -$4.03 in 2025, then jumped by 72.85% to -$1.09 in 2026.
- Business Quant data shows NDRA's EPS (Basic) at -$1.09 in Q1 2026, -$4.03 in Q4 2025, and -$2.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.74 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.23 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -0.47 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.20 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 1.45 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 4.29 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.37 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 11.57 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 3.66 |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.12 |
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -4.03 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -1.71 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | -8.57 |
| Sep 30, 2024 | -9.54 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.26 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | -0.43 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -1.14 |
| Sep 30, 2022 | -1.09 |
| Jun 30, 2022 | -1.17 |
| Mar 31, 2022 | -1.33 |
| Dec 31, 2021 | -1.52 |
| Sep 30, 2021 | -1.27 |